Is Vcanbio Cell & Gene stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Vcanbio Cell & Gene pays dividends. Last time was Thursday 1st of January 1970 where the investors holding the stock on Friday 10th of August 2001 were paid CNY0.0151 per share. Over the last 3 times between 1995 and 2001, Vcanbio Cell & Gene has paid CNY0.3919 with an average of CNY0.13 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Vcanbio Cell & Gene 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY19.99, you would have made a loss of CNY-3.44 per share or -17.21%
Yes, the average daily trading liquidity for Vcanbio Cell & Gene is CNY5.48 million. You should therefore be able to get in and out of your positions relatively fast.
Vcanbio Cell & Gene has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 8.21, the company's ability to pay off the debt is good. Vcanbio Cell & Gene has a good net profit margin of 6.81% and should have high tolerances against inflation.
We have calculated the inflation risk for Vcanbio Cell & Gene to be low [0.1 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.